Skip to main content

Feasibility of markerless tumor tracking by sequential dual-energy fluoroscopy on a clinical tumor tracking system

  • Conference paper
World Congress on Medical Physics and Biomedical Engineering, June 7-12, 2015, Toronto, Canada

Part of the book series: IFMBE Proceedings ((IFMBE,volume 51))

Abstract

Real-time tumor tracking (RTTT) through adaptation of the treatment beam has been reported to significantly reduce the treatment uncertainties related to respiratory induced motion in thoracic and abdominal tumors. However, the only two systems clinically available that are capable of performing this type of RTTT, both rely on implanted fiducials for accurate target localization on kV images, for the majority of lesions. The use of such fiducials is known to cause severe risks for complications, and the presence of possible marker migration with respect to the tumor. In this study, we evaluated the feasibility of markerless tumor tracking through the implementation of dual-energy imaging into the current clinical dynamic tracking (DT) workflow of the Vero SBRT system. As fast-switching kV generators are not readily available, a novel approach to dual-energy imaging was proposed, consisting of using two sequential fluoroscopic sequences. Incorporated at the beginning of the workflow of each DT treatment fraction on the Vero is a 20 s high-frequency (11 Hz) fluoroscopic sequence, using two orthogonal on-board kV imagers at ±45° from the MV beam. To enable dual-energy (DE) subtraction, another orthogonal fluoroscopic sequence, at the same gantry angle but al lower energy, was added into the workflow. Offline, through cross-correlation of the imaging sets from which the fiducial was removed, the best matching high- (HE) and low-energy couples per breathing phase were extracted for DE subtraction. A contrast analysis based on contrast-to-noise ratio was carried-out to evaluate improved tumor visibility between HE and DE images. The results, based on images from 7 lung cancer patients treated with DT on the Vero, suggest that DE subtraction can be used on the Vero system to enhance tumor visibility on kV images for markerless tumor localization, provided that all DE imaging parameters, such as imager settings and imaging angles, are optimized.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this paper

Cite this paper

Dhont, J. et al. (2015). Feasibility of markerless tumor tracking by sequential dual-energy fluoroscopy on a clinical tumor tracking system. In: Jaffray, D. (eds) World Congress on Medical Physics and Biomedical Engineering, June 7-12, 2015, Toronto, Canada. IFMBE Proceedings, vol 51. Springer, Cham. https://doi.org/10.1007/978-3-319-19387-8_145

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-19387-8_145

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-19386-1

  • Online ISBN: 978-3-319-19387-8

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics